Article

Response Monitoring in Children With Phenylketonuria

Department of Psychology, Washington University, St.Louis, MO 63130, USA.
Neuropsychology (Impact Factor: 3.43). 01/2009; 23(1):130-4. DOI: 10.1037/a0013488
Source: PubMed

ABSTRACT Phenylketonuria (PKU) is characterized by a disruption in the metabolism of phenylalanine and is associated with dopamine deficiency (Diamond, Prevor, Callender, & Druin, 1997) and cerebral white matter abnormalities (e.g., Anderson et al., 2007). From a neuropsychological perspective, prefrontal dysfunction is thought to underlie the deficits in executive abilities observed in individuals with PKU (Christ, Steiner, Grange, Abrams, & White, 2006; Diamond et al., 1997; White, Nortz, Mandernach, Huntington, & Steiner, 2001, 2002). The purpose of our study was to examine a specific aspect of executive ability, response monitoring, as measured by posterror slowing. The authors examined posterror reaction time (RT) in 24 children with well-controlled, early treated PKU and 25 typically developing control children using a go/no-go task. Results showed that RTs of both controls and children with PKU slowed significantly following the commission of errors. The magnitude of posterror slowing, however, was significantly less for children with PKU. These findings indicate deficient response monitoring in children with PKU.

0 Followers
 · 
112 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Phenylketonuria (PKU) is an inborn error of metabolism involving a deficiency of the enzyme phenylalanine hydroxylase. This condition results in elevated levels of phenylalanine and low levels of tyrosine. If left untreated, severe neuropathology and neurobehavioral sequelae manifest. The implementation of newborn screening and early dietary treatment has significantly reduced such morbidity. Despite relatively preserved general intellectual functioning, in early-treated PKU individuals subtle cognitive and behavioral deficits are still apparent. This paper provides a review of the evidence for impairment in information processing, executive function, memory and learning, academic achievement and behavior. This paper also reviews the two primary theories proposed to date relating to the underlying mechanisms for the cognitive and behavioral deficits encountered in treated PKU patients, namely prefrontal dysfunction and white matter abnormalities. Although more research is required, the literature to date suggests that early-treated PKU individuals are at risk of subtle neurobehavioral deficits across a range of neuropsychological domains. Thus, PKU patients should be closely monitored so that problems are detected early and appropriate interventions are put in place to ensure that individuals reach their full potential.
    Annales Nestlé (English ed ) 01/2010; 68(2):78-88. DOI:10.1159/000312815
  • [Show abstract] [Hide abstract]
    ABSTRACT: RésuméLa phénylcétonurie (PCU) est une erreur innée du métabolisme causée par un déficit de l’activité de la phénylalanine hydroxylase, induisant une phénylalaninémie élevée et une tyrosinémie faible. Si cette maladie n’est pas traitée, elle engendre une neuropathologie sévère associée à des troubles neurocomportementaux. Le dépistage néonatal et la mise en place précoce d’un régime alimentaire réduisent significativement ces morbidités. Malgré un fonctionnement intellectuel général relativement bien préservé, un déficit cognitif léger et de faibles troubles comportementaux persistent chez les patients traités. Cet article présente les données sur les altérations du traitement de l’information, des fonctions exécutives, de la mémoire et l’apprentissage, de la réussite scolaire et du comportement. Il présente également les deux premières théories, le dysfonctionnement préfrontal et les anomalies de la substance blanche, proposées pour expliquer les mécanismes sous-jacents de ces déficits cognitifs et comportementaux observés chez les patients traités. Bien que des recherches supplémentaires soient nécessaires, la littérature actuelle suggère que les patients phénylcétonuriques traités précocement pourraient présenter des risques de troubles neurocomportementaux légers dans différents domaines neuropsychologiques. Ces patients doivent donc être examinés régulièrement de façon à pouvoir détecter ces troubles le plus tôt possible et ainsi pouvoir mettre en place des interventions adaptées permettant à ces patients d’atteindre leur potentiel optimal.
    Annales Nestlé (Ed française) 01/2011; 68(2):79-89. DOI:10.1159/000323169
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Phenylketonuria (PKU) is a genetic disorder associated with disruption of prefrontal cortex (PFC) development and executive dysfunction. To date, however, there is little evidence directly linking these two sequelae of PKU. We utilized functional magnetic resonance imaging (fMRI) to evaluate prefrontal functioning in six individuals with early-treated PKU (ETPKU) during performance of an n-back working memory task and compared results with those of six age- and gender-matched neurologically intact individuals. In addition, we evaluated the possible presence of PKU-related disruptions in functional connectivity, as might be hypothesized based on prior reports of white matter injury in individuals with ETPKU. A number of brain regions, nearly half of which were located in the PFC, were found to show atypical neural activity in individuals with ETPKU during working memory performance. We also found decreased connectivity both within the PFC as well as between the PFC and other brain regions in individuals with ETPKU compared with controls. Results from this preliminary study suggest that both prefrontal dysfunction and disruptions in functional connectivity may contribute to PKU-related executive impairment. In addition to advancing our understanding of PKU, the current findings have a broader impact in that PKU is regularly used as a model of early prefrontal dysfunction in the study of other neurodevelopmental disorders (e.g., autism).
    Molecular Genetics and Metabolism 01/2010; 99 Suppl 1(Suppl. 1):S33-40. DOI:10.1016/j.ymgme.2009.09.014 · 2.83 Impact Factor
Show more